Assessing Metabolic Risk Factors for LVSI in Endometrial Cancer: A Cross-Sectional Study.

Authors:
Lin Q; Lu Y; Lu R; Chen Y; Wang L and 2 more

Journal:
Ther Clin Risk Manag

Publication Year: 2022

DOI:
10.2147/TCRM.S372371

PMCID:
PMC9375567

PMID:
35971461

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Ther Clin Risk Manag

Abbreviation: Ther Clin Risk Manag

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Health Care Sciences & Services

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Acthar Gel in African Americans versus Non-African Americans with Symptomatic Sarcoidosis: Physicia…
Bindra J; Chopra I; Hayes K and 3 more (2024) - Transparency Score: 3/6
Classification and Regression Tree Predictive Model for Acute Kidney Injury in Traumatic Brain Inju…
Wang R; Zhang J; He M and 1 more (2024) - Transparency Score: 3/6
Factors Influencing the Fasting Time in Adult Patients After the Endoscopic Management of Sharp Eso…
Wu DQ; Chen SY; Chen KG and 3 more (2024) - Transparency Score: 3/6
Profile of Sofosbuvir and Velpatasvir Combination in the Treatment of Chronic Hepatitis C in Childr…
Brigham D; Narkewicz MR. (2024) - Transparency Score: 2/6
Risk Factors of Chylothorax After Congenital Heart Surgery in Infants: A Single-Centre Retrospectiv…
Zhang RG; Liu YM; Yao ZY and 9 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure The authors declare that they have no conflicts of interest."

Evidence found in paper:

"Natural Science Foundation of Fujian Province (2021J01443)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025